The long-term goals of the proposed experiments are both to elucidate molecular-genetic controls over the neuron subtype-specific development of corticospinal motor neurons (CSMN) (and related neocortical projection neurons), and to potentially enable future approaches to repair of degenerating or injured CSMN. CSMN are both developmentally prototypical for all neocortical projection neurons, and clinically important as the brain neurons that degenerate in amyotrophic lateral sclerosis / motor neuron disease (ALS/MND) and whose axonal injury is central to loss of motor function in spinal cord injury. Proposed experiments will deeply investigate function of the centrally important CSMN/subcerebral-specific transcription factor CTIP2 (COUP-TF interacting protein 2) and its paralog CTIP1 in development of CSMN and related neurons in murine neocortex. Ctip2 has increasingly emerged as both a critical regulator of development and connectivity of CSMN, and as a common target for regulation (largely repression) by multiple projection neuron subtype differentiation pathways. Ctip2 is known from other organ systems to be involved in developmental lineage specification decisions. Within the neocortex, CTIP2 is specifically expressed by CSMN and related subcerebral projection neurons, and is necessary for outgrowth, fasciculation, and targeting of CSMN axons. While Ctip2 has emerged as centrally important for CSMN development, most aspects of its function remain unknown. Substantial preliminary data support these aims. Previous work from this laboratory identified Ctip2 as a critical CSMN molecular control, and demonstrated that CSMN axons in Ctip2-/- mice are misrouted before penetrating the internal capsule (IC), defasciculate in the IC, and fail to projec to the spinal cord (SC). Because CTIP2 also controls differentiation of striatal medium-sized spiny neurons (MSN), which surround CSMN axons in the IC, the hypothesis is suggested that some defects in Ctip2-/- CSMN connectivity to SC might result from dysregulation of axon growth and guidance controls in Ctip2-/- MSN. Mice lacking Ctip2 only in neocortex (Emx1-Cre;Ctip2fl/fl) reveal that a subset of CSMN enter and fasciculate in the IC, and some even reach the SC. Other preliminary studies find that the Ctip2 paralog Ctip1 interacts cross-repressively with Ctip2 to control deep-layer projection neuron development, and that Ctip1 additionally regulates areal organization. Proposed experiments will:
(Aims 1, 2) delineate CSMN-autonomous and non-CSMN-autonomous roles of Ctip2 in CSMN axon growth and fasciculation;
(Aims 3, 4) investigate a newly-identified genetically cross- repressive interaction between Ctip2 and its paralog Ctip1 in CSMN development, as well as independent roles of Ctip1 in areal organization and development of other deep-layer projection neurons. Experiments beyond this proposal could identify genes regulated directly or indirectly by Ctip2 in CSMN. These studies will elucidate mechanisms by which Ctip2, a central regulator of CSMN differentiation, acts alone and with other genes to instruct the precision of development of this developmentally prototypical, clinically important neuron type.

Public Health Relevance

Degenerative and traumatic neurological disorders are the source of great personal suffering and disability, and they account for a huge public health financial and social burden;these include neurodegenerative diseases involving cerebral cortex "long-connection" nerve cells termed "corticospinal motor neurons" (CSMN), such as ALS / "Lou Gehrig's disease", primary lateral sclerosis (PLS), hereditary spastic paraplegia (HSP), and Huntington's disease (HD);and traumatic spinal cord injury (SCI). A gene and molecule called Ctip2 has increasingly emerged as both a critical control over development and function of CSMN, and as a key regulatory "hub" for central pathways controlling brain development and function more generally, but most aspects of its function remain unknown. Building on recent work identifying molecular controls over these "cerebral cortex-to-spinal cord" brain neurons'growth and function, this project will pursue state-of-the-art investigation of how Ctip2 regulates the growth, health, and correct function of this important neuron type in mice, toward new approaches for the treatment of injured or degenerating neurons in the cerebral cortex, the highest region of the brain, that connect to the spinal cord and are central to human ALS, SCI, HSP, PLS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
1R01NS075672-01A1
Application #
8372817
Study Section
Neurogenesis and Cell Fate Study Section (NCF)
Program Officer
Owens, David F
Project Start
2012-05-01
Project End
2017-01-31
Budget Start
2012-05-01
Budget End
2013-01-31
Support Year
1
Fiscal Year
2012
Total Cost
$369,688
Indirect Cost
$150,938
Name
Harvard University
Department
Anatomy/Cell Biology
Type
Schools of Arts and Sciences
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Sadegh, Cameron; Macklis, Jeffrey D (2014) Established monolayer differentiation of mouse embryonic stem cells generates heterogeneous neocortical-like neurons stalled at a stage equivalent to midcorticogenesis. J Comp Neurol 522:2691-706
Cederquist, Gustav Y; Azim, Eiman; Shnider, Sara J et al. (2013) Lmo4 establishes rostral motor cortex projection neuron subtype diversity. J Neurosci 33:6321-32
Ravits, John; Appel, Stanley; Baloh, Robert H et al. (2013) Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis. Amyotroph Lateral Scler Frontotemporal Degener 14 Suppl 1:5-18
Greig, Luciano Custo; Woodworth, Mollie B; Galazo, Maria J et al. (2013) Molecular logic of neocortical projection neuron specification, development and diversity. Nat Rev Neurosci 14:755-69